Cell Source, Inc. (CLCS)
0.7308
+0.04
(+5.91%)
USD |
OTCM |
Apr 07, 15:59
Cell Source SG&A Expense (TTM) : 1.950M for Dec. 31, 2024
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Celldex Therapeutics, Inc. | 43.84M |
| Plus Therapeutics, Inc. | 12.13M |
| Atossa Therapeutics, Inc. | 15.96M |
| Abeona Therapeutics, Inc. | 65.03M |
| Kiora Pharmaceuticals, Inc. | 5.745M |